Craig Hallum Lowers eMagin (NYSEAMERICAN:EMAN) to Hold

Share on StockTwits

Craig Hallum lowered shares of eMagin (NYSEAMERICAN:EMAN) from a buy rating to a hold rating in a research note issued to investors on Tuesday morning, The Fly reports.

Several other research analysts have also issued reports on the company. Zacks Investment Research upgraded eMagin from a sell rating to a hold rating in a research report on Wednesday, July 10th. HC Wainwright set a $2.00 target price on eMagin and gave the company a buy rating in a research report on Monday, April 22nd.

Shares of NYSEAMERICAN:EMAN opened at $0.28 on Tuesday. eMagin has a 1 year low of $0.25 and a 1 year high of $1.70.

eMagin (NYSEAMERICAN:EMAN) last announced its earnings results on Tuesday, August 13th. The semiconductor company reported ($0.05) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.03) by ($0.02). The business had revenue of $5.36 million during the quarter, compared to analyst estimates of $7.70 million. During the same period in the previous year, the business earned ($0.11) EPS.

About eMagin

eMagin Corporation designs, develops, manufactures, and markets organic light emitting diode (OLED) displays on-silicon micro displays; virtual imaging products that utilize OLED micro displays; and related products. It offers super video graphics array (SVGA) + OLED micro displays; digital SVGA OLED-XL; super extended graphics array OLED-XL/XLS and OLED-XL; video graphics array OLED-XL; and widescreen ultra-extended graphics array OLED-XL/XLS.

Featured Story: What are momentum indicators and what do they show?

The Fly

Receive News & Ratings for eMagin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for eMagin and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Corindus Vascular Robotics  Downgraded by Zacks Investment Research to “Sell”
Corindus Vascular Robotics Downgraded by Zacks Investment Research to “Sell”
Craig Hallum Lowers eMagin  to Hold
Craig Hallum Lowers eMagin to Hold
Zacks Investment Research Upgrades Saipem  to Buy
Zacks Investment Research Upgrades Saipem to Buy
Castle Brands  Lowered to Hold at Zacks Investment Research
Castle Brands Lowered to Hold at Zacks Investment Research
Zacks Investment Research Lowers Rentokil Initial  to Sell
Zacks Investment Research Lowers Rentokil Initial to Sell
Zacks Investment Research Upgrades SThree  to Hold
Zacks Investment Research Upgrades SThree to Hold


© 2006-2019 Ticker Report